NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,391 | +20.0% | 148 | +208.3% | 0.00% | – |
| Q2 2023 | $1,992 | -82.2% | 48 | -74.2% | 0.00% | -100.0% |
| Q1 2023 | $11,187 | -42.9% | 186 | -30.3% | 0.00% | -50.0% |
| Q4 2022 | $19,584 | -34.7% | 267 | -32.2% | 0.00% | -50.0% |
| Q3 2022 | $30,000 | -3.2% | 394 | -12.4% | 0.00% | 0.0% |
| Q2 2022 | $31,000 | -38.0% | 450 | -25.1% | 0.00% | -33.3% |
| Q1 2022 | $50,000 | +212.5% | 601 | +175.7% | 0.01% | +200.0% |
| Q4 2021 | $16,000 | +166.7% | 218 | +327.5% | 0.00% | +100.0% |
| Q3 2021 | $6,000 | -81.8% | 51 | -65.3% | 0.00% | -80.0% |
| Q2 2021 | $33,000 | +230.0% | 147 | +104.2% | 0.01% | +150.0% |
| Q1 2021 | $10,000 | +900.0% | 72 | +928.6% | 0.00% | – |
| Q4 2020 | $1,000 | – | 7 | +75.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 4 | -94.7% | 0.00% | -100.0% |
| Q3 2019 | $5,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |